These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32394513)

  • 21. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Khan MS; Butler J
    N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Avidan MS; Dehbi HM; Delany-Moretlwe S
    N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
    Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
    S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
    [No Abstract]   [Full Text] [Related]  

  • 24. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    Okafor EC; Pastick KA; Rajasingham R
    N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
    [No Abstract]   [Full Text] [Related]  

  • 26. US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
    Shehab N; Lovegrove M; Budnitz DS
    JAMA Intern Med; 2020 Oct; 180(10):1384-1386. PubMed ID: 32628242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
    R Karim HM; Ahmed G
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):119-120. PubMed ID: 32773410
    [No Abstract]   [Full Text] [Related]  

  • 28. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
    Frishman WH
    Cardiol Rev; 2020; 28(5):217-218. PubMed ID: 32639241
    [No Abstract]   [Full Text] [Related]  

  • 29. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
    De Franceschi L; Costa E; Dima F; Morandi M; Olivieri O
    Eur J Intern Med; 2020 Oct; 80():103. PubMed ID: 32819797
    [No Abstract]   [Full Text] [Related]  

  • 30. Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.
    Seftel MD
    CMAJ; 2020 May; 192(18):E483. PubMed ID: 32366470
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hydroxychloroquine and chloroquine for COVID-19: no evidence of effectiveness].
    Vollaard A; Gieling EM; van der Linden PD; Sinha B; de Boer MGJ
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32749808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulators split on antimalarials for COVID-19.
    Jaffe S
    Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
    [No Abstract]   [Full Text] [Related]  

  • 33. Autophagy inhibition by chloroquine and hydroxychloroquine could adversely affect acute kidney injury and other organ injury in critically ill patients with COVID-19.
    Edelstein CL; Venkatachalam MA; Dong Z
    Kidney Int; 2020 Jul; 98(1):234-235. PubMed ID: 32437765
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Dec; 173(11):W156-W157. PubMed ID: 33085507
    [No Abstract]   [Full Text] [Related]  

  • 36. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
    Gies V; Bekaddour N; Dieudonné Y; Guffroy A; Frenger Q; Gros F; Rodero MP; Herbeuval JP; Korganow AS
    Front Immunol; 2020; 11():1409. PubMed ID: 32714335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].
    Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
    Medicina (B Aires); 2020; 80(3):271-274. PubMed ID: 32442941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Navigating COVID-19 in the developing world.
    Hodkinson B; Singh P; Gcelu A; Bautista-Molano W; Pons-Estel G; Alpízar-Rodríguez D
    Clin Rheumatol; 2020 Jul; 39(7):2039-2042. PubMed ID: 32462422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.